2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 1 - 6 of 18 drug pricing articles
A Haitian Family’s Journey: Getting Keytruda Treatment in the U.S. - 2026 Drug Cost Analysis

A Haitian Family’s Journey: Getting Keytruda Treatment in the U.S.

30 views

When Marie, a Haitian mother, was diagnosed with metastatic melanoma, her oncologist recommended Keytruda, a groundbreaking immunotherapy. While offering hope, the treatment’s high cost and insurance complexities posed serious challenges. This article explores the latest 2025 pricing, insurance options, and patient assistance programs that make Keytruda accessible for Haitian and U.S. families alike.

Is CAR-T Therapy Covered by Insurance in the U.S.? (2026 Update) - 2026 Drug Cost Analysis

Is CAR-T Therapy Covered by Insurance in the U.S.? (2026 Update)

8 views

CAR-T cell therapy remains one of the most promising yet expensive cancer treatments in 2026. This detailed guide explains whether insurance companies in the U.S. — including Medicare, Medicaid, and private plans — cover CAR-T therapy. We also include updated treatment prices, hospital billing comparisons, and available financial assistance options to help patients manage costs.

How Much Does Keytruda Cost with Insurance in the U.S.? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost with Insurance in the U.S.?

33 views

In 2026, most patients pay between $300 and $3,000 per month depending on their plan, deductible, and location. This complete guide breaks down Keytruda prices with and without insurance, Medicare coverage, patient assistance programs, and expert insights to help Americans save on cancer treatment costs.

Will Zepbound Really Get Cheaper in 2026? What Experts Predict - 2026 Drug Cost Analysis

Will Zepbound Really Get Cheaper in 2026? What Experts Predict

186 views

Wondering if Zepbound will finally become more affordable in 2026? As one of the most discussed weight-loss medications in the U.S., many Americans are hoping for price drops as new competitors and insurance changes emerge. This article explores what experts predict, compares Zepbound’s current and expected costs, and highlights financial assistance programs that could help you save in 2026.

Donanemab Cost in 2026: Alzheimer’s Drug Price, Medicare Coverage & Patient Assistance Options - 2026 Drug Cost Analysis

Donanemab Cost in 2026: Alzheimer’s Drug Price, Medicare Coverage & Patient Assistance Options

59 views

Donanemab (Kisunla), Eli Lilly’s Alzheimer’s therapy, is priced around $32,000 per year in 2024–2025 and may rise slightly by 2026. This guide covers the latest projected prices, Medicare and insurance coverage, out-of-pocket estimates, and patient assistance programs available in the U.S. Compare Donanemab vs Leqembi costs, understand CMS registry requirements, and find financial aid options for Alzheimer’s patients.

Keytruda Cost in 2026: What You’ll Actually Pay (Latest U.S. Data & Savings Tips) - 2026 Drug Cost Analysis

Keytruda Cost in 2026: What You’ll Actually Pay (Latest U.S. Data & Savings Tips)

37 views

In 2026, the real cost of Keytruda (pembrolizumab) continues to rise across the U.S., with list prices now reaching $11,564 per 200 mg dose or $23,590 for the 400 mg / 6-week schedule. While insurance coverage, assistance programs, and Medicare options can significantly reduce out-of-pocket costs, many American patients still face bills ranging from $1,200 to $10,000 per month, depending on their plan. This article breaks down updated Keytruda pricing data for 2026, compares infusion costs by hospital and pharmacy, explains copay assistance options, and provides the latest policy updates about potential government price negotiations. You’ll also find detailed FAQs addressing what patients in the U.S. are actually paying, how insurance affects coverage, and where to find verified cost-saving programs. Read on to discover the latest Keytruda prices, insurance breakdowns, and patient support options available in 2026.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings